AlphaFold predicted structure
MMP13 · P45452

Mean pLDDT
88.6/ 100
Confident
471 residues
Confidence breakdown
- Very high(≥ 90)75%
- Confident(70–90)14%
- Low(50–70)4%
- Very low(< 50)8%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
matrix metallopeptidase 13
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
DDG2P
BOTH monoallelic and biallelic, autosomal or pseudoautosomalFetal anomalies
BOTH monoallelic and biallelic, autosomal or pseudoautosomalSkeletal dysplasia
BOTH monoallelic and biallelic, autosomal or pseudoautosomalIntellectual disability
BOTH monoallelic and biallelic, autosomal or pseudoautosomalOsteogenesis imperfecta
spondyloepimetaphyseal dysplasia, Missouri type
metaphyseal anadysplasia
metaphyseal chondrodysplasia, Spahr type
acne
rosacea
periodontitis
infection
spotted fever
typhus
pneumonia
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Collagenase 3
Plays a role in the degradation of extracellular matrix proteins including fibrillar collagen, fibronectin, TNC and ACAN. Cleaves triple helical collagens, including type I, type II and type III collagen, but has the highest activity with soluble type II collagen. Can also degrade collagen type IV, type XIV and type X. May also function by activating or degrading key regulatory proteins, such as TGFB1 and CCN2. Plays a role in wound healing, tissue remodeling, cartilage degradation, bone development, bone mineralization and ossification. Required for normal embryonic bone development and ossification. Plays a role in the healing of bone fractures via endochondral ossification. Plays a role in wound healing, probably by a mechanism that involves proteolytic activation of TGFB1 and degradation of CCN2. Plays a role in keratinocyte migration during wound healing. May play a role in cell migration and in tumor cell invasion
MMP13 · P45452

Mean pLDDT
88.6/ 100
Confident
471 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0